Fundraising FoxCareSkore
4 known investors
Find your way into CareSkore
Sign up to find every way you can get introduced to CareSkore
- Your email: who you already know at CareSkore, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CareSkore team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
CareSkore offers an AI and machine learning platform for healthcare providers that aggregates and normalizes patient data to predict population health risks and generate regulatory reports such as PQRS, HEDIS, and MACRA. Its tools include risk prediction (Zeus), automated bidirectional patient communication (Iris), and performance management and reporting (Apollo) aimed at improving clinical and financial outcomes.
Investors · 4
How we know: Cota Capital's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · blog.stormventures.com · Not right? Tell us
Funding
SEC filings, press & company announcements$4.3M disclosed across 1 round · 2016
- $4.3MraisedAug 2016 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does CareSkore do?
- CareSkore offers an AI and machine learning platform for healthcare providers that aggregates and normalizes patient data to predict population health risks and generate regulatory reports such as PQRS, HEDIS, and MACRA. Its tools include risk prediction (Zeus), automated bidirectional patient communication (Iris), and performance management and reporting (Apollo) aimed at improving clinical and financial outcomes.
- Who are CareSkore's investors?
- CareSkore's investors include Cota Capital, Rising Tide, Liquid Ventures, Storm Ventures.
- How much funding has CareSkore raised?
- CareSkore has disclosed $4.3M raised across 1 round.